A phase II trial investigating the highly selective c-Met inhibitor tepotinib in stage IIIB/IV lung adenocarcinoma with MET exon 14 alterations after failure of at least one prior therapy Meeting Abstract
| Authors: | Paik, P. K.; Stammberger, U.; Bruns, R. |
| Abstract Title: | A phase II trial investigating the highly selective c-Met inhibitor tepotinib in stage IIIB/IV lung adenocarcinoma with MET exon 14 alterations after failure of at least one prior therapy |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi450 |
| Language: | English |
| ACCESSION: | WOS:000393913000384 |
| DOI: | 10.1093/annonc/mdw383.92 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1292TiP -- Source: Wos |
